Will CBD replace steroid creams? Dermatological studies and support thesis (Lampoon Magazine)

Adam Friedman, MD, FAAD

CBD – or cannabidiol, the second most prevalent active ingredient in cannabis – and active cannabinoids are gaining attention in the beauty industry. Despite ongoing claims confusion, complex regulatory hurdles and a lack of consumer confidence due to greenwashing, the popularity is especially increasing within skincare. 

Adam Friedman, MD, professor and chair of the Department of Dermatology at the George Washington University School of Medicine and Health Sciences, comments on the uses of CBD on curing topical inflammation, use of nanotechnology and the future of cannabinoids in skincare. 

Read the full article on LampoonMagazine.com.

Latest News

The GW Medical Faculty Associates is pleased to announce that Steven W. Boyce, MD, will serve as Chief of the Division of Cardiac Surgery. He also serves as a Professor of Surgery. The division, which is part of the larger Department of Surgery, is home to a broad group of nationally and…
Air quality in the Washington, D.C. area is unusually poor, and while it may be invisible some days, the threat is still there. Daniel Baram, MD, associate professor of medicine at the George Washington (GW) School of Medicine and Health Sciences (SMHS) and division Director of Pulmonary Medicine…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce the selection of Karen A. Fagan, MD, to serve as the Chair of the GW Department of Medicine.